11β Hydroxysteroid dehydrogenase - 1 activity in type 2 diabetes mellitus: a comparative study.
Ravindra ShuklaAsish Kumar BasuBiplab MandalPradip MukhopadhyayAnimesh MaitySatyam ChakrabortyPraveen Kumar DevrabhaiPublished in: BMC endocrine disorders (2019)
11β HSD 1 activity is higher in type 2 diabetes mellitus subjects, especially those who are lean. Future 11 β HSD 1 inhibitors targeting metabolic syndrome, will be most useful in those with increased fasting blood glucose. The role of DHEAS and vitamin D status needs to be explored.